Welcome To The
Hereditary Neuropathy Foundation
Our mission is to increase awareness and accurate diagnosis of Charcot-Marie-Tooth (CMT) and related inherited neuropathies, support patients and families living with CMT, and fund research that will lead to treatments and cures.
Latest News From HNF
Hope on the Horizon: CMT & FDA Patient-Focused Drug Development Meeting for Charcot-Marie-Tooth to be Held in 2018
HNF will be holding a landmark externally-led Patient-Focused Drug Development (PFDD) Meeting CMT & INs in Washington, D.C. on September 28, 2018. The meeting will be held in conjunction with September National CMT Awareness Month.read more
Pharnext completed patient enrollment for the international Phase 3 clinical trial of PXT3003, Pharnext’s lead PLEODRUG ©, for treatment of CMT1A.read more
HNPP is the second most common form of CMT/IN and may affect approximately 15,000 in the USA. Help us find a cure today!read more
TD Bank Five Boro Bike Tour
May 6, 2018
Come ride with HNF for CMT awareness.
Externally-Led Patient-Focused Drug Development CMT Meeting
Washington, D.C. ~ September 28th, 2018
HNF will be holding a landmark externally-led Patient-Focused Drug Development (PFDD) Meeting for CMT and INs in Washington, D.C. on Friday, September 28, 2018.